Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer
$398,919N03FY2013CANIH
Investigators
Abstract
The objective of this Statement of Work is to assess the cancer prevention efficacy of the Muc1 vaccine alone in hMuc1.p48Cre.LSLKras G12D and p48Cre.LSL-Kras G12D mice as follows.
View original record on NIH RePORTER →